Comparison of the effectiveness of topical product containing henna and turmeric with a Persian medicine based formulation with placebo in patients with contact dermatitis. Triple-blind clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 33 人开始时间: 待定最近更新: 2022年5月2日

适应症

试验速览

暂无简介。

•Age 18 years and above
•Acute or recurrent contact dermatitis in a person with a history of mild to moderate contact dermatitis (baseline Three Item Severity score in the range of 1 to 6)
•Declare the written consent of the patient to participate in the study and the desire to attend regular treatment and follow-up courses
•Have a minimum score of one for the redness and itching option in the Three Item Severity score

•Other types of dermatitis except contact dermatitis
•Use of topical dermatitis medications (except moisturizers) in the last 2 weeks or systemic medications in the last 4 weeks
•Taking steroids or systemic immunosuppressants with any indication
•Pregnant and lactating women
•Severe contact dermatitis (Three Item Severity = 9)
•Alcohol or drug addiction
•Heart disease, kidney disease or asthma
•Active skin disease other than contact dermatitis
•History of allergies to topical medications or cosmetics (with documentation)
•Tattooing, scarring, and hyperpigmentation at the lesion site
•History of any malignant disease or active cancer
•G6PD enzyme deficiency

发起方